Related references
Note: Only part of the references are listed.Nifedipine, a Calcium-Channel Blocker, Attenuated Glucose Intolerance and White Adipose Tissue Dysfunction in Type 2 Diabetic KK-Ay Mice
Masaru Iwai et al.
AMERICAN JOURNAL OF HYPERTENSION (2011)
Beneficial Effects of L- and N-type Calcium Channel Blocker on Glucose and Lipid Metabolism and Renal Function in Patients with Hypertension and Type II Diabetes Mellitus
Takashi Masuda et al.
CARDIOVASCULAR THERAPEUTICS (2011)
Nifedipine increases energy expenditure by increasing PGC-1α expression in skeletal muscle
Zhe Tian et al.
HYPERTENSION RESEARCH (2011)
Serum high-molecular-weight adiponectin as a marker for the evaluation and care of subjects with metabolic syndrome and related disorders
Hiroshi Hirose et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2010)
Cilnidipine suppresses podocyte injury and proteinuria in metabolic syndrome rats: possible involvement of N-type calcium channel in podocyte
Yu-Yan Fan et al.
JOURNAL OF HYPERTENSION (2010)
The Metabolic Syndrome and Cardiovascular Risk A Systematic Review and Meta-Analysis
Salvatore Mottillo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Adipose tissue as an endocrine organ
Sandra Galic et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies
Shoba Shetty et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
High-molecular weight adiponectin is independently associated with the extent of coronary artery disease in men
Maximilian von Eynatten et al.
ATHEROSCLEROSIS (2008)
Glucose sensing and the pathogenesis of obesity and type 2 diabetes
B. Thorens
INTERNATIONAL JOURNAL OF OBESITY (2008)
Effects of doxazosin on blood flow and mRNA expression of nitric oxide synthase in the spontaneously hypertensive rat genitourinary tract
Makoto Yono et al.
LIFE SCIENCES (2007)
Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans
Reiko Nakashima et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Telmisartan prevents obesity and increases the expression of uncoupling protein 1 in diet-induced obese mice
Kana Araki et al.
HYPERTENSION (2006)
The metabolic syndrome and adipocytokines
Yuji Matsuzawa
FEBS LETTERS (2006)
Telmisartan but not valsartan increases caloric expenditure and protects against weight gain and hepatic steatosis
K Sugimoto et al.
HYPERTENSION (2006)
The Role of Adipocytokines and Neurohormonal Dysregulation in Metabolic Syndrome
Alice Pik-Shan Kong et al.
CURRENT DIABETES REVIEWS (2006)
Adrenergic receptor stimulation attenuates insulin-stimulated glucose uptake in 3T3-L1 adipocytes by inhibiting GLUT4 translocation
AH Mulder et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Adiponectin and adiponectin receptors
T Kadowaki et al.
ENDOCRINE REVIEWS (2005)
Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin
H Kobayashi et al.
CIRCULATION RESEARCH (2004)
Adiponectin protects LPS-induced liver injury through modulation of TNF-α in KK-Ay obese mice
T Masaki et al.
HEPATOLOGY (2004)
Elevated sympathetic activity may promote insulin resistance syndrome by activating alpha-1 adrenergic receptors on adipocytes
MF McCarty
MEDICAL HYPOTHESES (2004)
Adiponectin and atherosclerotic disease
K Shimada et al.
CLINICA CHIMICA ACTA (2004)
Inflammation: the link between insulin resistance, obesity and diabetes
P Dandona et al.
TRENDS IN IMMUNOLOGY (2004)
Peripheral, but not central, administration of adiponectin reduces visceral adiposity and upregulates the expression of uncoupling protein in agouti yellow (Ay/a) obese mice
T Masaki et al.
DIABETES (2003)
Effect of cilnidipine on insulin sensitivity in patients with essential hypertension
S Yagi et al.
HYPERTENSION RESEARCH (2003)
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
T Yamauchi et al.
NATURE MEDICINE (2002)
Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans
N Stefan et al.
DIABETES (2002)
Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys
K Hotta et al.
DIABETES (2001)
Share Paper
